CEO Adam Steensberg explains that this summer season’s optimistic trial information and capital injection has made Zealand Pharma transfer sooner with higher breadth and depth.
发布者：BY CHRISTOPHER DUE KARLSSON，转转请注明出处：https://robotalks.cn/zealand-pharma-raises-cost-outlook-amid-push-for-weight-loss-drug-development/
Customer companies and unions in the United States desire regulatory authorities to quit Novo Holdings’ procurement of Catalent.
Mid-tier gold manufacturer Frying pan African Resources has actually obtained the staying 92% of Tennant Consolidated Mining Team (TCMG) in Australia. The business revealed on Nove…
Un nuevo estudio propone que un potente láser espacial podría ser la fuente de la misteriosa señal “Wow!” que ha desconcertado a los astrónomos durante casi 50 años. La…
LUBIANA, Slovenia–(BUSINESS WIRE)–La sera del 23 ottobre ora locale, Dongfeng Motor ha ospitato con successo la cerimonia di apertura del Dongfeng Middle a Lubiana, cap…
The Chartered Institute of Logistics and Transportation UK (CILT(UK)) has actually included in a news-style program created by ITN Service called ‘Changing Logistics: Accurac…
